Measurement of the subjective effects of methylphenidate in 11- to 15-year-old children with attention-deficit/hyperactivity disorder

Catherine A. Martin, Greg Guenthner, Christopher M Bingcang, Mary Kay Rayens, Thomas H. Kelly

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective: This study examined subjective and other behavioral effects of methylphenidate (MPH) among adolescents. Methods: Standard abuse liability assessment methods that have been used in adult populations were modified for attention-deficit/hyperactivity disorder (ADHD) adolescents. MPH effects (0, 0.25 mg/kg) were evaluated under randomized, double-blind conditions in two 5-hour laboratory sessions in 24 (13 female) 11-15 year olds diagnosed with ADHD. Results: Repeated measures analysis of covariance indicated significant dose and dose by time interactions on subjective ratings on the modified amphetamine (A) [F (1, 20) = 5.98; p < 0.05; η2 = 0.36], morphine-benzedrine group (MBG) [F (1, 21) = 8.93 p < 0.01; η2 = 0.38] and benzedrine group scale (BG) [F (1, 21) + 13.10 p < 0.01; η2 = 0.37] scales of the Addiction Research Center Inventory; "Hungry" and "How sure are you that you got the medication today?" from the Visual Analogue Scale, the Profile of Mood States Depression scale, performance on the Continuous Performance Task, heart rate and blood pressure, and level of activity. Conclusions: This is the first study to document subjective effects of stimulants in adolescents with ADHD that have been associated with drug abuse potential in adults. There are increasing concerns about nontherapeutic stimulant use in adolescents and young adults. Assessing subjective effects of pharmacotherapies for ADHD along with other measures of abuse potential such as drug self-administration may aid in assessing the therapeutic effects and/or risk of medications used in the treatment of ADHD.

Original languageEnglish (US)
Pages (from-to)63-73
Number of pages11
JournalJournal of Child and Adolescent Psychopharmacology
Volume17
Issue number1
DOIs
StatePublished - Feb 1 2007

Fingerprint

Methylphenidate
Attention Deficit Disorder with Hyperactivity
Self Administration
Task Performance and Analysis
Therapeutic Uses
Amphetamine
Visual Analog Scale
Morphine
Substance-Related Disorders
Young Adult
Heart Rate
Depression
Blood Pressure
Drug Therapy
Equipment and Supplies
Research
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Measurement of the subjective effects of methylphenidate in 11- to 15-year-old children with attention-deficit/hyperactivity disorder. / Martin, Catherine A.; Guenthner, Greg; Bingcang, Christopher M; Rayens, Mary Kay; Kelly, Thomas H.

In: Journal of Child and Adolescent Psychopharmacology, Vol. 17, No. 1, 01.02.2007, p. 63-73.

Research output: Contribution to journalArticle

@article{306bab8a8920407d8b9bb4ba6fe5f423,
title = "Measurement of the subjective effects of methylphenidate in 11- to 15-year-old children with attention-deficit/hyperactivity disorder",
abstract = "Objective: This study examined subjective and other behavioral effects of methylphenidate (MPH) among adolescents. Methods: Standard abuse liability assessment methods that have been used in adult populations were modified for attention-deficit/hyperactivity disorder (ADHD) adolescents. MPH effects (0, 0.25 mg/kg) were evaluated under randomized, double-blind conditions in two 5-hour laboratory sessions in 24 (13 female) 11-15 year olds diagnosed with ADHD. Results: Repeated measures analysis of covariance indicated significant dose and dose by time interactions on subjective ratings on the modified amphetamine (A) [F (1, 20) = 5.98; p < 0.05; η2 = 0.36], morphine-benzedrine group (MBG) [F (1, 21) = 8.93 p < 0.01; η2 = 0.38] and benzedrine group scale (BG) [F (1, 21) + 13.10 p < 0.01; η2 = 0.37] scales of the Addiction Research Center Inventory; {"}Hungry{"} and {"}How sure are you that you got the medication today?{"} from the Visual Analogue Scale, the Profile of Mood States Depression scale, performance on the Continuous Performance Task, heart rate and blood pressure, and level of activity. Conclusions: This is the first study to document subjective effects of stimulants in adolescents with ADHD that have been associated with drug abuse potential in adults. There are increasing concerns about nontherapeutic stimulant use in adolescents and young adults. Assessing subjective effects of pharmacotherapies for ADHD along with other measures of abuse potential such as drug self-administration may aid in assessing the therapeutic effects and/or risk of medications used in the treatment of ADHD.",
author = "Martin, {Catherine A.} and Greg Guenthner and Bingcang, {Christopher M} and Rayens, {Mary Kay} and Kelly, {Thomas H.}",
year = "2007",
month = "2",
day = "1",
doi = "10.1089/cap.2006.0020",
language = "English (US)",
volume = "17",
pages = "63--73",
journal = "Journal of Child and Adolescent Psychopharmacology",
issn = "1044-5463",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Measurement of the subjective effects of methylphenidate in 11- to 15-year-old children with attention-deficit/hyperactivity disorder

AU - Martin, Catherine A.

AU - Guenthner, Greg

AU - Bingcang, Christopher M

AU - Rayens, Mary Kay

AU - Kelly, Thomas H.

PY - 2007/2/1

Y1 - 2007/2/1

N2 - Objective: This study examined subjective and other behavioral effects of methylphenidate (MPH) among adolescents. Methods: Standard abuse liability assessment methods that have been used in adult populations were modified for attention-deficit/hyperactivity disorder (ADHD) adolescents. MPH effects (0, 0.25 mg/kg) were evaluated under randomized, double-blind conditions in two 5-hour laboratory sessions in 24 (13 female) 11-15 year olds diagnosed with ADHD. Results: Repeated measures analysis of covariance indicated significant dose and dose by time interactions on subjective ratings on the modified amphetamine (A) [F (1, 20) = 5.98; p < 0.05; η2 = 0.36], morphine-benzedrine group (MBG) [F (1, 21) = 8.93 p < 0.01; η2 = 0.38] and benzedrine group scale (BG) [F (1, 21) + 13.10 p < 0.01; η2 = 0.37] scales of the Addiction Research Center Inventory; "Hungry" and "How sure are you that you got the medication today?" from the Visual Analogue Scale, the Profile of Mood States Depression scale, performance on the Continuous Performance Task, heart rate and blood pressure, and level of activity. Conclusions: This is the first study to document subjective effects of stimulants in adolescents with ADHD that have been associated with drug abuse potential in adults. There are increasing concerns about nontherapeutic stimulant use in adolescents and young adults. Assessing subjective effects of pharmacotherapies for ADHD along with other measures of abuse potential such as drug self-administration may aid in assessing the therapeutic effects and/or risk of medications used in the treatment of ADHD.

AB - Objective: This study examined subjective and other behavioral effects of methylphenidate (MPH) among adolescents. Methods: Standard abuse liability assessment methods that have been used in adult populations were modified for attention-deficit/hyperactivity disorder (ADHD) adolescents. MPH effects (0, 0.25 mg/kg) were evaluated under randomized, double-blind conditions in two 5-hour laboratory sessions in 24 (13 female) 11-15 year olds diagnosed with ADHD. Results: Repeated measures analysis of covariance indicated significant dose and dose by time interactions on subjective ratings on the modified amphetamine (A) [F (1, 20) = 5.98; p < 0.05; η2 = 0.36], morphine-benzedrine group (MBG) [F (1, 21) = 8.93 p < 0.01; η2 = 0.38] and benzedrine group scale (BG) [F (1, 21) + 13.10 p < 0.01; η2 = 0.37] scales of the Addiction Research Center Inventory; "Hungry" and "How sure are you that you got the medication today?" from the Visual Analogue Scale, the Profile of Mood States Depression scale, performance on the Continuous Performance Task, heart rate and blood pressure, and level of activity. Conclusions: This is the first study to document subjective effects of stimulants in adolescents with ADHD that have been associated with drug abuse potential in adults. There are increasing concerns about nontherapeutic stimulant use in adolescents and young adults. Assessing subjective effects of pharmacotherapies for ADHD along with other measures of abuse potential such as drug self-administration may aid in assessing the therapeutic effects and/or risk of medications used in the treatment of ADHD.

UR - http://www.scopus.com/inward/record.url?scp=33947405758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947405758&partnerID=8YFLogxK

U2 - 10.1089/cap.2006.0020

DO - 10.1089/cap.2006.0020

M3 - Article

VL - 17

SP - 63

EP - 73

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

SN - 1044-5463

IS - 1

ER -